Despite rising prevalence of heart disease in China, primary preventive treatment rates remain low

Disclosure: This site contains some affiliate links. We might receive a small commission at no additional cost to you.

Written & Supervised By
Preventive Medicine and Public Health Specialist | 40+ Years Experience

Medically Reviewed
Dr. Jose Rossello, MD, PhD, MHCM
Preventive Medicine & Public Health Specialist
Last Reviewed: February 21, 2019

Despite rising prevalence of heart disease in China, primary preventive treatment rates remain low American College of Physicians
M18-3301
URLs go live when the embargo lifts
About one in 10 middle-aged adults in China are at high risk for cardiovascular disease (CVD), yet use of risk reduction therapies is strikingly low. Findings from a Chinese national screening project are published in Annals of Internal Medicine .

Read the source article at EurekAlert! Science News[1]

References

  1. Read the source article at EurekAlert! Science News. Accessed December 2, 2025
author avatar
Jose Rossello, MD, PhD, MHCM
Dr. Rossello is a medical doctor specializing in Preventive Medicine and Public Health. He founded PreventiveMedicineDaily.com to provide evidence-based health information supported by authoritative medical research.
See Full Bio
Previous
Next
Leave a Comment

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}